← Back to Screener
MDxHealth SA Ordinary Shares (MDXH)
Price$0.66
Value ScoreB
Growth ScoreB
Momentum ScoreF
Favorite Metrics
Price vs S&P 500 (26W)-92.55%
Price vs S&P 500 (4W)-68.08%
VGM Score51.81
Market Capitalization$34.41M
All Metrics
Book Value / Share (Quarterly)$0.12
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)42.79%
Cash Flow / Share (Quarterly)$-0.08
Price vs S&P 500 (YTD)-89.65%
Gross Margin (TTM)64.00%
Net Profit Margin (TTM)-30.98%
EPS (TTM)$-1.00
10-Day Avg Trading Volume0.98M
EPS Excl Extra (TTM)$-1.00
Revenue Growth (5Y)42.34%
EPS (Annual)$-0.67
ROI (Annual)-50.76%
Gross Margin (Annual)64.55%
Net Profit Margin (5Y Avg)-76.80%
Cash / Share (Quarterly)$0.84
Revenue Growth QoQ (YoY)12.74%
ROA (Last FY)-24.25%
Revenue Growth TTM (YoY)18.19%
EBITD / Share (TTM)$-0.33
ROE (5Y Avg)-376.22%
Operating Margin (TTM)-15.07%
Cash Flow / Share (Annual)$-0.42
P/B Ratio5.77x
P/B Ratio (Quarterly)11.78x
Net Income / Employee (Annual)$-107,400
EV / Revenue (TTM)0.60x
Net Interest Coverage (TTM)-0.82x
ROA (TTM)-33.39%
EPS Incl Extra (Annual)$-0.67
Current Ratio (Annual)1.56x
Quick Ratio (Quarterly)1.38x
3-Month Avg Trading Volume0.40M
52-Week Price Return-64.82%
Revenue / Employee (TTM)$521,500
P/S Ratio (Annual)0.32x
Asset Turnover (Annual)0.57x
52-Week High$5.33
Operating Margin (5Y Avg)-60.57%
EPS Excl Extra (Annual)$-0.67
CapEx CAGR (5Y)16.46%
26-Week Price Return-76.62%
Quick Ratio (Annual)1.43x
13-Week Price Return-78.59%
Total Debt / Equity (Annual)4.00x
Current Ratio (Quarterly)1.63x
Enterprise Value$97.14M
Revenue / Share Growth (5Y)-0.54%
Asset Turnover (TTM)1.08x
Revenue / Employee (Annual)$345,800
Inventory Turnover (Annual)10.50x
Pretax Margin (Annual)-32.79%
Cash / Share (Annual)$0.96
3-Month Return Std Dev110.00%
Gross Margin (5Y Avg)57.37%
Net Income / Employee (TTM)$-161,500
ROE (Last FY)-253.79%
Net Interest Coverage (Annual)-0.98x
EPS Basic Excl Extra (Annual)$-0.67
Receivables Turnover (TTM)10.92x
Total Debt / Equity (Quarterly)14.07x
EPS Incl Extra (TTM)$-1.00
Receivables Turnover (Annual)6.85x
ROI (TTM)-48.61%
P/S Ratio (TTM)0.21x
Pretax Margin (5Y Avg)-77.06%
Revenue / Share (Annual)$2.16
Price vs S&P 500 (52W)-93.03%
Year-to-Date Return-78.71%
5-Day Price Return-5.01%
EPS Normalized (Annual)$-0.67
ROA (5Y Avg)-44.62%
Net Profit Margin (Annual)-31.07%
Month-to-Date Return-62.75%
EBITD / Share (Annual)$-0.12
Operating Margin (Annual)-13.50%
LT Debt / Equity (Annual)4.93x
ROI (5Y Avg)-81.66%
LT Debt / Equity (Quarterly)12.63x
EPS Basic Excl Extra (TTM)$-1.00
P/B Ratio (Annual)7.82x
Inventory Turnover (TTM)10.95x
Pretax Margin (TTM)-32.12%
Book Value / Share (Annual)$0.31
Price vs S&P 500 (13W)-88.34%
Beta0.53x
Revenue / Share (TTM)$3.12
ROE (TTM)-304.96%
52-Week Low$0.68
vGradeB
gGradeB
mGradeF
vgmGradeC
Show chart for
Earnings Surprise History
Q1 26-0.17est. -0.15
Analyst Recommendations
Feb 2026
Mar 2026
Apr 2026
May 2026
4.33
4.33
4.33
4.33
Industry Peers — Health Services(28)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
MDXHMDxHealth SA Ordinary Shares | B | B | F | $0.66 |
| NTRANatera, Inc. Common Stock | F | A | B | $218.81 |
| DGXQuest Diagnostics Inc. | C | D | C | $192.20 |
| LHLabcorp Holdings Inc. | C | D | C | $256.87 |
| EXASExact Sciences Corp | F | B | B | $0.00 |
| GHGuardant Health, Inc. Common Stock | F | A | A | $129.14 |
| CELCCelcuity Inc. Common Stock | — | — | B | $122.96 |
| CAICaris Life Sciences, Inc. Common Stock | F | F | C | $16.45 |
| RDNTRadNet, Inc. Common Stock | D | C | D | $52.89 |
| VCYTVeracyte, Inc. | D | A | B | $48.18 |
| GRALGRAIL, Inc. Common Stock | D | A | B | $64.40 |
About
MDxHealth SA develops molecular diagnostic tests for cancer using proprietary genomic and epigenetic technologies. Its tests help physicians diagnose urologic cancers and predict treatment response and recurrence risk. The company generates revenue through clinical laboratory services and by licensing its DNA methylation platform to partners. It operates in the United States and Europe.